Bausch + Lomb Investor Relations Material
Latest events
Q2 2025
Bausch + Lomb
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bausch + Lomb Corporation
Access all reports
Bausch + Lomb Corporation is a global healthcare company specializing in eye health products. The company offers a wide range of products across three primary segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. Its portfolio includes contact lenses, lens care solutions, prescription eye medications, over-the-counter eye care products, and surgical devices for cataract, vitreoretinal, and refractive procedures. The company is headquartered in Vaughan, Canada, and its shares are listed on the NYSE (New York Stock Exchange).
Key slides for Bausch + Lomb Corporation
Q3 2024
Bausch + Lomb Corporation
43rd Annual J.P. Morgan Healthcare Conference 2025
Bausch + Lomb Corporation
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BLCO
Country
🇨🇦 Canada